Department of Surgery, University of Tsukuba, Graduate School of Comprehensive Human Sciences, 1-1-1 Tennodai, Tsukuba, Japan.
Eur J Surg Oncol. 2011 Jan;37(1):60-4. doi: 10.1016/j.ejso.2010.10.011. Epub 2010 Nov 20.
Few studies have investigated the influence of the lymph node ratio (LNR), the ratio of the number of lymph nodes harboring metastatic cancer to the total number of lymph nodes removed, on the outcome after surgery for extrahepatic cholangiocarcinoma. This study was conducted to examine the prognostic impact of LNR in patients undergoing resection for extrahepatic cholangiocarcinoma.
We retrospectively analyzed a total of 60 consecutive patients who underwent resection for extrahepatic cholangiocarcinoma. We focused on the LNR, which was classified as 0 in 34 patients, between 0 and 0.2 in 13 patients, and greater than 0.2 in 13 patients.
The overall five-year survival rates for patients with LNRs of 0, 0 to 0.2, and ≥0.2 were 44%, 10%, and 0%, respectively (p = 0.023). LNR was an independent predictive factor for estimated survival by both univariate (p = 0.016) and multivariate (p = 0.022) analyses including LNR, the sites of the primary tumors, and surgical margin as the variables. There were no statistically significant differences between patients who had less than 12 lymph nodes removed and those who had 12 or more lymph nodes removed (p = 0.484).
LNR was a powerful, independent predictor of estimated survival in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. LNR should be considered when stratifying patients for future clinical trials.
很少有研究调查淋巴结比率(LNR),即含有转移性癌症的淋巴结数量与切除的总淋巴结数量之比,对肝外胆管癌手术后结局的影响。本研究旨在研究 LNR 对接受肝外胆管癌切除术患者的预后影响。
我们回顾性分析了 60 例连续接受肝外胆管癌切除术的患者。我们重点关注 LNR,其中 34 例为 0,13 例为 0 至 0.2,13 例大于 0.2。
LNR 为 0、0 至 0.2 和≥0.2 的患者总体五年生存率分别为 44%、10%和 0%(p=0.023)。LNR 是单因素(p=0.016)和多因素(p=0.022)分析包括 LNR、肿瘤原发部位和手术切缘作为变量)预测估计生存率的独立预测因子。切除的淋巴结少于 12 个与切除 12 个或更多淋巴结的患者之间没有统计学差异(p=0.484)。
LNR 是接受肝外胆管癌手术切除患者估计生存率的有力独立预测因子。在为未来的临床试验分层患者时,应考虑 LNR。